You are here

  • Home
  • Archive
  • Volume 9, Issue 1
  • Methylation status of vault RNA 2-1 promoter is a predictor of glycemic response to glucagon-like peptide-1 analog therapy in type 2 diabetes mellitus

Article info

Article menu
XML
Genetics/Genomes/Proteomics/Metabolomics
Methylation status of vault RNA 2-1 promoter is a predictor of glycemic response to glucagon-like peptide-1 analog therapy in type 2 diabetes mellitus

Authors

  • Chia-Hung Lin Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou and College of Medicine, Chang Gung University, Taoyuan, Taiwan PubMed articlesGoogle scholar articles
  • Yun-Shien Lee Genomic Medicine Research Core Laboratory, Chang Gung Memorial Hospital, Linkou Main Branch, Taoyuan, TaiwanDepartment of Biotechnology, Ming Chuan University, Taoyuan, Taiwan PubMed articlesGoogle scholar articles
  • Yu-Yao Huang Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou and College of Medicine, Chang Gung University, Taoyuan, Taiwan PubMed articlesGoogle scholar articles
  • Chi-Neu Tsai Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, TaiwanDepartment of Surgery, New Taipei Municipal Tucheng Hospital, New Taipei City, Taiwan PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Chi-Neu Tsai; pink7{at}cgu.edu.tw
View Full Text

Citation

Lin C, Lee Y, Huang Y, et al
Methylation status of vault RNA 2-1 promoter is a predictor of glycemic response to glucagon-like peptide-1 analog therapy in type 2 diabetes mellitus
BMJ Open Diabetes Research and Care 2021;9:e001416. doi: 10.1136/bmjdrc-2020-001416

Publication history

  • Received March 28, 2020
  • Revised January 28, 2021
  • Accepted February 7, 2021
  • First published March 5, 2021.
Online issue publication 
January 24, 2024

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.